Particle.news

Peer-Reviewed Study Validates Six-Hour Urine Test for Targeted UTI Treatment

High agreement with reference testing supports Astratus's push toward clinical use.

Overview

  • The University of Reading–led team, in results published Tuesday, March 31 in the Journal of Antimicrobial Chemotherapy, found the test delivers answers in an average of 5.85 hours with 96.95% agreement across seven first-line antibiotics.
  • The assay skips overnight culture by dipping a microcapillary cartridge loaded with different antibiotics into urine and using optical imaging to see if bacteria grow or stop in each tube.
  • A validation on 90 duplicate samples showed 98.75% agreement between urine stored with boric acid preservative and without it, indicating the method fits routine collection workflows.
  • Researchers and clinicians say same-day matching of the right drug could reduce needless antibiotic use, slow resistance, and lower the chance a UTI advances to severe illness such as sepsis.
  • Astratus, a University of Reading spinout, is preparing to commercialize the validated prototype, though the reports do not indicate regulatory clearance or widespread clinical deployment yet.